布地奈德和异丙托溴铵氧驱动雾化吸入治疗毛细支气管炎临床疗效观察

目的：观察布地奈德和异丙托溴铵氧驱动雾化吸入治疗毛细支气管炎的临床疗效。方法：将68例毛细支气管炎患儿随机分为两组,两组均给予常规治疗,在此基础上,观察组35例给予布地奈德和异丙托溴铵氧驱动面罩雾化吸入。对照组33例给予庆大霉素、α-糜蛋白酶、地塞米松进行超声雾化吸入。疗程均为5～7d,2次/d,观察两组的疗效。结果：观察组总有效率为97.14%,高于对照组的66.67%,差异有统计学意义（P〈0.01）。结论：布地奈德和异丙托溴铵氧驱动雾化吸入治疗毛细支气管炎疗效明显高于对照组,且缩短了疗程,药物全身不良反应小,更简便易行,值得临床推广应用。

Budesonide and Ipratropium Bromide Oxygen Drive Atomization Inhalation on Bronchiolitis Clinical Curative Effect Observation

Objective：To observe the effect of budesonide and ipratropium bromide oxygen atomizing inhalation to treat bronchiolitis clinical curative effect.Method：68 cases of bronchiolitis were randomly divided into 2 groups,two groups were given routine treatment,the observation group 35 cases were given budesonide,ipratropium bromide oxygen drive atomization inhalation mask too.33 patients of control group were given gentamicin too,chymotrypsin,ultrasonic atomizing inhalation of dexamethasone.Treatment lasted for 5-7 days,2 times/day,curative effect of the two groups were observed.Result：In the observation group,the total efficiency was 97.14%,it’s higher than 66.67% in the control group,the difference was statistically significant（P ＆lt;0.01）.Conclusion：Budesonide and ipratropium bromide oxygen atomizing inhalation treatment of bronchiolitis is significantly higher than that of the control group,and shorten the course of treatment,the general drug adverse reactions.it’s more convenient,and worthy of clinical application.